BlackRock, Inc. 13D and 13G filings for Alexion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-09 3:23 pm Sale |
2021-07-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN |
BLACKROCK INC BLK |
0 0.000% |
-18,168,276 (Position Closed) |
Filing |
| 2021-02-05 07:51 am Purchase |
2020-12-31 | 13G | Alexion Pharmaceuticals, Inc. ALXN |
BLACKROCK INC BLK |
18,168,276 8.300% |
2,254,905 (+14.17%) |
Filing |